PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32733468-8	2020	Tofacitinib inhibited early Mo-DC differentiation, decreasing both CD209 and CD40 activation markers in RA.	tofacitinib	0-11	CD209 molecule	Homo sapiens	67-72	
31721311-4	2020	When assessing the effects of tofacitinib on monocyte-derived DCs, we observed reduced differentiation of monocytes into immature DCs, as evidenced by a decreased transcription of CD209 and CD80.	tofacitinib	30-41	CD209 molecule	Homo sapiens	180-185